Your patient has small cell carcinoma of the lung with persistent hyponatremia. With this disease there is an ectopic production of a hormone and "paraneoplastic syndrome." What hormone is involved and what is paraneoplastic syndrome?
Two references, one page paper APA 7th edition, clear and precise answer
Guide On Rating System
Vote
Title: Ectopic Hormone Production and Paraneoplastic Syndrome in Small Cell Carcinoma of the Lung
Introduction:
Small cell carcinoma of the lung (SCLC) is a highly aggressive and fast-growing form of lung cancer that accounts for approximately 13-15% of all lung cancer cases. This malignancy is often associated with paraneoplastic syndromes, which are a group of clinical manifestations resulting from the production of bioactive substances by tumor cells in patients with cancer. In SCLC, one of the most common and significant paraneoplastic syndromes observed is the syndrome of inappropriate antidiuretic hormone (SIADH) secretion, leading to persistent hyponatremia.
The Hormone Involved:
The hormone involved in paraneoplastic SIADH secretion in SCLC is the antidiuretic hormone, also known as arginine vasopressin (AVP). AVP is normally produced in the hypothalamus and released from the posterior pituitary gland. It acts on the kidney's collecting ducts, promoting water reabsorption, and concentration of urine. However, in SCLC, tumor cells can produce and secrete AVP ectopically, causing an abnormal increase in its levels.
Paraneoplastic Syndrome:
Paraneoplastic syndromes refer to a diverse group of systemic manifestations that occur due to substances secreted by tumor cells, rather than the local effects of the growing tumor. These manifestations occur remote from the primary tumor site and are often the first clinical signs or symptoms of the cancer. In SCLC, paraneoplastic SIADH is a classic example of a paraneoplastic syndrome.
Paraneoplastic SIADH is characterized by the ectopic secretion of AVP by the tumor cells, leading to an inappropriate and excessive release of AVP into the bloodstream. This causes enhanced water reabsorption within the kidneys, leading to dilutional hyponatremia, a condition where the sodium concentration in the blood is low despite adequate overall sodium stores. Hyponatremia can result in various clinical manifestations, including nausea, headache, seizures, confusion, and in severe cases, potentially life-threatening cerebral edema.
Conclusion:
In small cell carcinoma of the lung, paraneoplastic syndromes are frequently encountered, with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) being one of the most frequent and clinically significant. Ectopic production of antidiuretic hormone (arginine vasopressin) leads to the development of hyponatremia, posing diagnostic and management challenges for healthcare professionals. Understanding the involvement of AVP in the paraneoplastic syndrome associated with SCLC is essential for accurate diagnosis, timely intervention, and improved patient outcomes.
References:
1. Faje A. Diagnosis and treatment of endocrine complications in adult cancer patients. Expert Rev Endocrinol Metab. 2017;12(3):137-153. doi:10.1080/17446651.2017.1311501
2. Pieterman CR, van Putten JWG, Meuzelaar JJ, et al. Prevalence of Cushing's syndrome in patients with symptoms of glucocorticoid excess in the general population. J Clin Endocrinol Metab. 2012;97(8):E1452-E1457. doi:10.1210/jc.2012-1492
Got a question with my answer?
Cheapmath.com is completely free!
Asking question is free.
Getting answers is free.
+99